JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C200166200 on April 2, 2002

J. Biol. Chem., Vol. 277, Issue 21, 18249-18252, May 24, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/21/18249    most recent
C200166200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Archer, D. A.
Right arrow Articles by Burgoyne, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Archer, D. A.
Right arrow Articles by Burgoyne, R. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
Complexin Regulates the Closure of the Fusion Pore during Regulated Vesicle Exocytosis*

Deborah A. ArcherDagger, Margaret E. Graham, and Robert D. Burgoyne§

From The Physiological Laboratory, University of Liverpool, Crown Street, Liverpool L69 3BX, United Kingdom

Received for publication, March 20, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Membrane fusion during exocytosis and throughout the cell is believed to involve members of the SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors) family of proteins. The assembly of these proteins into a four-helix bundle may be part of the driving force for bilayer fusion. Regulated exocytosis in neurons and related cell types is specialized to be fast and Ca2+-dependent suggesting the involvement of other regulatory proteins specific for regulated exocytosis. Among these are the complexins, two closely related proteins that bind only to the assembled SNARE complex. We have investigated the function of complexin by analysis of single vesicle release events in adrenal chromaffin cells using carbon fiber amperometry. These cells express complexin II, and overexpression of this protein modified the kinetics of vesicle release events so that their time course was shortened. This effect depended on complexin interaction with the SNARE complex as introduction of a mutation of Arg-59, a residue that interacts with synaptobrevin in the SNARE complex, abolished its effects. The data are consistent with a function for complexin in stabilizing an intermediate of the SNARE complex to allow kiss-and-run recycling of the exocytosed vesicle.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SNARE1 (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors) proteins associate to form a SNARE complex (1) that has a crucial role in membrane fusion events throughout the secretory pathway as the core of a highly conserved fusion machinery (2). The SNARE proteins syntaxin, SNAP-25, and vesicle-associated membrane protein (synaptobrevin), involved in regulated exocytosis in neurons and neuroendocrine cells, have been studied in most detail (3, 4). From in vitro studies, the neuronal SNAREs are sufficient for membrane fusion when reconstituted in liposomes (5), but this occurs in a Ca2+-independent manner and with kinetics that are many orders of magnitude slower than exocytosis at the synapse suggesting an essential requirement for other proteins. A prime candidate for a protein that influences membrane fusion during regulated exocytosis is complexin (6, 7) as it binds specifically to the assembled SNARE complex (6, 8, 9).

Regulated exocytosis differs significantly from other membrane fusion events. First, it is dependent upon an intracellular signal such as an elevated Ca2+ concentration for its initiation (10). Second, in synapses it is specialized to be able to occur within tens of microseconds of Ca2+ elevation (11) through the rapid formation of a transient fusion pore (12). Third, rapid retrieval of the fused membrane is essential to maintain the releasable vesicle pool (13). It is likely that proteins in addition to SNAREs are crucially important for the control and kinetics of fast, regulated exocytosis. Numerous proteins have been discovered that interact with the neuronal SNARE proteins, and some of these are not expressed in organisms such as yeast that lack regulated exocytosis. It is likely that these proteins either impose Ca2+ sensitivity on the fusion machinery (e.g. synaptotagmin) or contribute to the fast kinetics of membrane fusion or retrieval during synaptic vesicle exocytosis. Complexin binds to the assembled SNARE complex competitively with alpha -SNAP (6). Knockout of either one of the two complexin isoforms, I and II, produces a mild (II) or moderate (I) phenotype (14, 15). In contrast, the double complexin I/II knockout mouse dies shortly after birth and shows a marked impairment of Ca2+-evoked neurotransmission (15). The exact contribution of complexin to SNARE complex assembly is controversial (9, 16), but recent structural data suggest binding of a single complexin to each independent SNARE complex via association of the complexin C-terminal domain with residues from syntaxin and synaptobrevin (9, 17). Here we have investigated the function of complexin by analysis of single vesicle release events in adrenal chromaffin cells using amperometry and demonstrated a novel effect of complexin II on release kinetics that depends on its interaction with the SNARE complex. The data are consistent with a function for complexin in controlling the closure of the fusion pore to elicit rapid kiss-and-run recycling of the exocytosed vesicle.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmids-- A plasmid encoding complexin II (6) was provided by Harvey McMahon (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK). The coding region was amplified by polymerase chain reaction and ligated into pcDNA3.1. Site-directed mutagenesis was used to generate the R59H mutation using the QuikChange system (Stratagene). The primers were: sense, 5'-CATGGAAGCGGAACATGAGAAGGTCCGG-3'; and antisense, 5'-CCGGACCTTCTCATGTTCCGCTTCCATG-3'.

Cell Culture and Transfection of Chromaffin Cells-- Isolated bovine adrenal chromaffin cells (18) were plated on non-tissue culture-treated 10-cm Petri dishes and left overnight at 37 °C. Non-attached cells were resuspended in growth medium at a density of 1 × 107/ml. Plasmids (encoding EGFP and complexins) were mixed and added at 2 µg/1 × 106 cells, and cells were electroporated using a Bio-Rad Gene Pulser II (Bio-Rad). The cells were then rapidly diluted to 1 × 106/ml with fresh growth medium and added to 35-mm Petri dishes, made up to a volume of 3 ml with fresh growth medium, and maintained in culture for 3-5 days.

Immunofluorescence-- Transfections were performed as described above, and cells were plated onto round glass coverslips (13-mm diameter). After washing twice with PBS, cells were fixed in 4% formaldehyde in PBS for a minimum of 30 min at room temperature. Cells were then washed twice in PBS, incubated for 30 min in blocking buffer (0.3% bovine serum albumin, 0.5% Triton X-100 in PBS), and incubated overnight at 4 °C with L668 rabbit polyclonal antibody against complexin II (provided by Dr. Harvey McMahon) at a 1:500 dilution. Cells were then washed three times, incubated for 1 h in biotinylated anti-rabbit IgG (Amersham Biosciences) at a 1:100 dilution, washed three times, and finally incubated in streptavidin-Texas Red (Amersham Biosciences) at a 1:50 dilution for 30 min. After being mounted onto slides, cells were viewed with appropriate filters to visualize EGFP and immunofluorescence.

Western Blotting-- HeLa cells were trypsinized, plated at a density of 1 × 107 on 35-mm plates, and cultured in Dulbecco's modified Eagle's medium with 5% fetal bovine serum. After 5 h, the cells were transfected with 1 µg of plasmid (pcDNA3 or the plasmids encoding complexin II or complexin II(R59H)) using 3 µl of FuGENE transfection reagent (Roche Molecular Biochemicals). After an additional 72 h, the cells were lysed in 200 µl of SDS dissociation buffer. Chromaffin cells were plated onto 35-mm plates and lysed in 200 µl of SDS dissociation buffer after 3 days. Synaptosomes were provided by Gareth Evans (The Physiology Laboratory, University of Liverpool, UK). Samples were separated by SDS-PAGE, transferred to nitrocellulose, and probed with L668 rabbit polyclonal antibody against complexin II (1:1000), and bands were visualized using enhanced chemiluminescence (Amersham Biosciences).

Amperometric Recording-- Cells were washed twice with PBS, incubated in bath buffer (139 mM potassium glutamate, 0.2 mM EGTA, 20 mM PIPES, 2 mM ATP, and 2 mM MgCl2, pH 6.5) and viewed using a Nikon TE300 inverted microscope. Transfected cells were identified as those expressing EGFP. A 5-µm-diameter carbon fiber electrode was positioned in contact with a cell. For stimulation, a glass micropipette filled with cell permeabilization/stimulation buffer (139 mM potassium glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM ATP, 2 mM MgCl2, 20 µM digitonin, and 10 µM free Ca2+, pH 6.5) was positioned on the opposite side of the cell from the carbon fiber. An Eppendorf Transjector was used to pressure eject the buffer onto the cell for a 20-s pulse. Amperometric responses were monitored with a VA-10 amplifier (NPI Electronic), collected at 4 kHz, and digitized with a Digidata 1322A acquisition system. Data were subsequently analyzed using an automated peak detection and analysis protocol with the technical graphics program Origin (Microcal) (19). All the data are shown as mean ± S.E., and statistical differences were assessed using the non-parametric Mann Whitney test.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Complexin I is expressed mainly in neurons, but complexin II is expressed more widely. We, therefore, examined whether complexin II is expressed in adrenal chromaffin cells by immunoblotting with anti-complexin II. A single band was detected in chromaffin cells, whereas an additional smaller polypeptide due to cross-reaction with complexin I (6) was also detected in rat brain synaptosomes (Fig. 1A) suggesting that chromaffin cells express mainly complexin II. Complexin II was detected in both membrane and soluble pools from chromaffin cells. For examination of complexin II function in chromaffin cells, we aimed to overexpress wild-type protein and a form with the R59H mutation. Arg-59 in complexin makes crucial contacts with synaptobrevin in the SNARE complex and is likely to be crucial for complexin binding to the complex (17). In chromaffin cells, co-transfected to express EGFP, expression of both complexin proteins above endogenous levels could be demonstrated (Fig. 1B). The transfection efficiency for chromaffin cells is too low to demonstrate expression by immunoblotting. Analysis of expression levels was carried out using HeLa cells, therefore, where similar expression levels of both wild-type and mutant proteins could be demonstrated following transfection (Fig. 1C).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Expression and overexpression of complexin II. A, samples of isolated bovine chromaffin cells and rat brain synaptosomes were analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting with anti-complexin II. A single band corresponding to complexin II was detected in chromaffin cells (even after prolonged exposure of the blot), whereas an additional smaller band corresponding to complexin I was detected in synaptosomes. B, overexpression of complexin II or complexin II(R59H) was observed in EGFP-expressing chromaffin cells after transfection using immunofluorescence with anti-complexin II at levels of antiserum that gave only background staining of untransfected cells (arrow). C, comparison of expression levels of complexin II and complexin II(R59H) in transfected HeLa cells by immunoblotting. CPXII, complexin II.

The effect of overexpression of complexin II on the extent of exocytosis and the characteristics and kinetics of single vesicle release events was examined using carbon fiber amperometry (20). In each case data from transfected cells were directly compared with data from control, untransfected cells in the same dishes and using the same carbon fibers (28-38 cells for each condition). Complexin II overexpression partially inhibited exocytosis and also reduced the average charge released in each spike (Fig. 2) showing that less catecholamine was released during each exocytotic event (a reduction in quantal size). To determine whether these effects were due to interaction of complexin II with the SNARE complex or some nonspecific effect we examined the consequence of expressing the specific R59H mutant of complexin II. The specificity of the complexin II effect on exocytosis was demonstrated by the finding that complexin II(R59H) had no effect on the extent of exocytosis or on quantal size in transfected cells (Fig. 3).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Amperometric recording of evoked exocytosis and the effect of overexpression of complexin II. A, example traces from a control (untransfected) cell and a cell transfected to express complexin II (CPXII). B, values for the number of spikes per cell following stimulation shown as mean ± S.E. (n = 38 for controls, n = 28 for complexin II-expressing cells). C, values for charge (area) per spike shown as mean ± S.E. (n = 465 spikes for controls, n = 164 for complexin II-expressing cells). Cont, control.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Amperometric recording of evoked exocytosis and the effect of expression of complexin II(R59H). A, example traces from a control (untransfected) cell and a cell transfected to express complexin II(R59H). B and C, values for the mean number of spikes per cell (n = 33 for controls, n = 30 for complexin II(R59H)-expressing cells) and mean values of charge per spike (n = 681 spikes for controls, n = 533 spikes for complexin(R59H)-expressing cells). Cont, control; CPXII, complexin II; n.s., not significant.

The characteristics of the amperometric spikes in chromaffin cells overexpressing complexin II or the R59H mutant were examined in more detail. Overexpression of complexin II modified the shape of the amperometric spikes resulting in significant decreases in height, half-width, rise time to peak, and fall time (Fig. 4A). The effect of complexin II on the frequency distribution of events is shown for half-width, which reveals a shift to a population with narrower half-widths (Fig. 4B). In contrast, expression of complexin II(R59H) had no effect on any of the spike parameters examined. Similar reductions in half-width and rise time to those seen in complexin II-overexpressing cells have been seen in chromaffin cells expressing the Munc18(R39C) mutant that has reduced affinity for syntaxin (21) and also following phorbol ester treatment (19). In both cases these modifications were not accompanied by changes in spike height. As a consequence, spikes in cells expressing Munc18(R39C) or treated with phorbol 12-myristate 13-acetate showed a significant increase in the rate of rise of the spikes due to the decreased rise time (Fig. 4C). In contrast, this parameter was unaffected by overexpression of complexin II or the complexin II(R59H) mutant. These data suggest that complexin II does not modulate the initial rate of the release events, but the reduced half-width and charge suggest that it leads instead to premature termination of the release event. The shape of the resulting amperometric spikes demonstrates this point. The changes in amperometric spikes (Fig. 4D) were distinct from those in cells in which catecholamine was depleted as these showed both a reduction in height and in the initial rate of rise of the spikes (21).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Modification of amperometric spike parameters by overexpression of complexin II. A, spike parameters from cells overexpressing complexin II or expressing complexin II(R59H) were compared with the respective controls, and differences (%) are shown. B, frequency distribution of spike half-widths from control and complexin II-overexpressing cells. C, comparison of the effects of treatment with phorbol 12-myristate 13-acetate (PMA) and expression of Munc18(R39C), complexin II, or complexin II(R59H) on the rate of rise of the amperometric spikes. The data for Munc18(R39C) were recalculated from Ref. 21. D, overlay of spikes from a control cell and a cell overexpressing complexin II to illustrate the overall differences in spike shape based on the mean values for spike parameters. n.s., not significant; CPXII, complexin II; HW, half-width.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our data show that overexpression of complexin II in chromaffin cells has two effects, an inhibition of the number of exocytotic events and also changes in the kinetics of single vesicle release events consistent with kiss-and-run exocytosis (22). In the crystal structure of the complexin-SNARE complex, Arg-59 of complexin makes a crucial interaction between complexin and the SNAREs (17). The reduced length of the histidine side chain compared with arginine in the R59H mutant we tested would prevent the formation of the salt bridge observed between this residue and Asp-57 of synaptobrevin. Mutation of this residue prevented the effects of complexin overexpression on both the extent and the characteristics of the release events showing that these effects were dependent on interaction of complexin II with the SNARE complex. The interaction of complexin with Asp-57 is close to the conserved zero layer residues of the SNARE complex. Mutation of the zero layer residues does not, however, have any effect on the kinetics of exocytosis (23, 24). The inhibitory effect of complexin II on spike number is consistent with previous data showing reduced exocytosis in transfected PC12 cells overexpressing complexin I or II (25) or following acute microinjection of complexin II into Aplysia neurons (26). This inhibitory effect was ascribed to competitive inhibition by complexin of alpha -SNAP association with cis-SNARE complexes as it was antagonized by co-injection of alpha -SNAP. The effect we observed here on the kinetics of release events cannot be explained by competition with alpha -SNAP as we have shown that expression of a dominant negative alpha -SNAP mutant inhibited exocytosis in chromaffin cells but did not modify spike kinetics (27). Similarly spike kinetics were not modified by a reduction in SNARE availability in cells transfected to express clostridial neurotoxins (19).

We and others have previously demonstrated that the kinetics of catecholamine release and extent of release can be modified at the level of a single vesicle (21, 27-31). We have interpreted these data as reflecting changes in the kinetics of fusion pore expansion and fusion pore open time (32). In support of the latter aspect we have found that spike half-width and quantal size are increased by disruption of dynamin function (33) indicating that the release time course is sensitive to disruption of dynamin-dependent vesicle retrieval. The effect of complexin II overexpression on spike parameters was to some extent similar to that seen in cells expressing the Munc18(R39C) mutant or after treatment with phorbol ester (19, 21) as in all cases spike half-width and quantal size were reduced. In contrast, however, the initial rate of spike rise was increased by Munc18(R39C) and phorbol ester but not by complexin II overexpression. These data suggest that complexin II was unusual in that it did not modify the rate of fusion pore expansion, but instead its major effect was to limit the time over which release occurred. This is consistent with complexin inducing earlier fusion pore closure to give rise to kiss-and-run exocytosis. Such a specific effect on vesicle release events has not previously been described under any other conditions.

Biochemical analysis of complexin has been limited to examination of its interaction with assembled cis-SNARE complexes (as would occur within the same membrane) (6, 8, 9, 17). Membrane fusion is mediated by trans-SNARE complexes that bridge two membranes. Various studies, for example using clostridial neurotoxins, have indicated the existence in cells of multiple trans-SNARE complexes assembled to differing extents prior to exocytosis (34, 35). One possible role for complexins would be to stabilize a trans-SNARE complex intermediate that would be able to allow rapid fusion pore closure after exocytosis. The rapid binding kinetics of complexins to assembled SNAREs suggests that this interaction could occur during or following membrane fusion. This suggested role for complexins in favoring kiss-and-run exocytosis could be consistent with the phenotype of complexin I/II knockout mice that show a loss of fast synchronous neurotransmission (15). This is maintained by rapid recycling of a small preferentially released pool of synaptic vesicles that is reused over a time course of 1-3 s (36). It is possible, therefore, that kiss-and-run exocytosis induced by complexins could be essential for the rapid internalization of vesicles into the ready releasable pool. The deficit in complexin I/II knockout mice can be overcome by elevating Ca2+ concentration (15) that could activate other pathways for rapid vesicle retrieval. Other functional aspects of complexin interaction with the SNARE complex cannot be ruled out, however. The ability of complexins to regulate both the extent of exocytosis and nature of vesicle recycling would make it a likely target for mechanisms regulating synaptic plasticity.

    ACKNOWLEDGEMENTS

We thank Dr. Harvey McMahon (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for the plasmid encoding complexin II and for complexin II antiserum and Dr. Gareth Evans (Department of Physiology, University of Liverpool, UK) for the gift of rat brain synaptosomes.

    FOOTNOTES

* This work was supported by a grant from the Wellcome Trust (to R. D. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by a Wellcome Trust prize studentship.

§ To whom correspondence should be addressed. Tel.: 44-151-794-5305; Fax: 44-151-794-5337; E-mail: burgoyne@liverpool.ac.uk.

Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.C200166200

    ABBREVIATIONS

The abbreviations used are: SNARE, soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors; SNAP, soluble N-ethylmaleimide-sensitive fusion attachment protein; EGFP, enhanced green fluorescent protein; PBS, phosphate-buffered saline; PIPES, 1,4-piperazinediethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
2. Jahn, R., and Sudhof, T. C. (1999) Annu. Rev. Biochem. 68, 863-911[CrossRef][Medline] [Order article via Infotrieve]
3. Chen, Y. A., and Scheller, R. H. (2001) Nat. Rev. Mol. Cell Biol. 2, 98-106[CrossRef][Medline] [Order article via Infotrieve]
4. Sutton, R. B., Fasshauer, D., Jahn, R., and Brunger, A. T. (1998) Nature 395, 347-353[CrossRef][Medline] [Order article via Infotrieve]
5. Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Sollner, T. H., and Rothman, J. E. (1998) Cell 92, 759-772[CrossRef][Medline] [Order article via Infotrieve]
6. McMahon, H. T., Missler, M., Li, C., and Sudhof, T. C. (1995) Cell 83, 111-119[CrossRef][Medline] [Order article via Infotrieve]
7. Ishizuka, T., Saisu, H., Odani, S., and Abe, T. (1995) Biochem. Biophys. Res. Commun. 213, 1107-1114[CrossRef][Medline] [Order article via Infotrieve]
8. Pabst, S., Hazzard, J. W., Antonin, W., Sudhof, T. C., Jahn, R., Rizo, J., and Fasshauer, D. (2000) J. Biol. Chem. 275, 19808-19818[Abstract/Free Full Text]
9. Pabst, S., Margittai, M., Vainus, D., Langen, R., Jahn, R., and Fasshauer, D. (2002) J. Biol. Chem. 277, 7838-7848[Abstract/Free Full Text]
10. Burgoyne, R. D., and Morgan, A. (1995) Trends Neurosci. 18, 191-196[CrossRef][Medline] [Order article via Infotrieve]
11. Sabatini, B. L., and Regehr, W. G. (1996) Nature 384, 170-172[CrossRef][Medline] [Order article via Infotrieve]
12. Lindau, M., and Almers, W. (1995) Curr. Opin. Cell Biol. 7, 509-517[CrossRef][Medline] [Order article via Infotrieve]
13. Harata, N., Pyle, J. L., Aravanis, A. M., Mozhayeva, M., Kavali, E. T., and Tsien, R. W. (2001) Trends Neurosci. 24, 637-643[CrossRef][Medline] [Order article via Infotrieve]
14. Takahashi, S.-i., Ujihara, H., Huang, G.-Z., Yagyu, K.-i., Sanbo, M., Kaba, H., and Yagi, T. (1999) Eur. J. Neurosci. 11, 2359-2366[CrossRef][Medline] [Order article via Infotrieve]
15. Reim, K., Mansour, M., Varoqueaux, F., McMahon, H. T., Sudhof, T. C., Brose, N., and Rosenmund, C. (2001) Cell 104, 71-81[CrossRef][Medline] [Order article via Infotrieve]
16. Tokumaru, H., Umayahara, K., Pellegrini, L. L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G. J., and Abe, T. (2001) Cell 104, 421-432[CrossRef][Medline] [Order article via Infotrieve]
17. Chen, X., Tomchick, D. R., Kovrigin, E., Arac, D., Machius, M., Sudhof, T. C., and Rizo, J. (2002) Neuron 33, 397-409[CrossRef][Medline] [Order article via Infotrieve]
18. Burgoyne, R. D. (1992) in Neuromethods: Intracellular Messengers (Boulton, A. , Baker, G. , and Taylor, C., eds), Vol. 20 , pp. 433-470, Humana Press Inc., Totowa, NJ
19. Graham, M. E., Fisher, R. J., and Burgoyne, R. D. (2000) Biochimie (Paris) 82, 469-479[Medline] [Order article via Infotrieve]
20. Schroeder, T. J., Borges, R., Finnegan, J. M., Pihel, J., Amatore, C., and Wightman, R. M. (1996) Biophys. J. 70, 1061-1068[Abstract/Free Full Text]
21. Fisher, R. J., Pevsner, J., and Burgoyne, R. D. (2001) Science 291, 875-878[Abstract/Free Full Text]
22. Fesce, R., Grohovaz, F., Valtorta, F., and Meldolesi, J. (1994) Trends Cell Biol. 4, 1-4[CrossRef][Medline] [Order article via Infotrieve]
23. Graham, M. E., Washbourne, P., Wilson, M. C., and Burgoyne, R. D. (2001) J. Cell Sci. 114, 4397-4405[Abstract/Free Full Text]
24. Finley, M. F. A., Patel, S. M., Madison, D. V., and Scheller, R. H. (2002) J. Neurosci. 22, 1266-1272[Abstract/Free Full Text]
25. Itakura, M., Misawa, H., Sekiguchi, M., Takahashi, S., and Takahashi, M. (1999) Biochem. Biophys. Res. Commun. 265, 691-696[CrossRef][Medline] [Order article via Infotrieve]
26. Ono, S., Baux, G., Sekiguchi, M., Fossier, P., Morel, N. F., Nihonmatsu, I., Hirata, K., Awaji, T., Takahashi, S., and Takahashi, M. (1998) Eur. J. Neurosci. 10, 2143-2152[CrossRef][Medline] [Order article via Infotrieve]
27. Graham, M. E., and Burgoyne, R. D. (2000) J. Neurosci. 20, 1281-1289[Abstract/Free Full Text]
28. Elhamdani, A., Martin, T. F. J., Kowalchyk, J. A., and Artalejo, C. R. (1999) J. Neurosci. 19, 7275-7383
29. Criado, M., Gil, A., Viniegra, S., and Gutierrez, L. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7256-7261[Abstract/Free Full Text]
30. Machado, J. D., Morales, A., Gomez, J. F., and Borges, R. (2001) Mol. Pharmacol. 60, 514-520[Abstract/Free Full Text]
31. Wang, C.-T., Grishanin, R., Earles, C. A., Chang, P. Y., Martin, T. F. J., Chapman, E. R., and Jackson, M. B. (2001) Science 294, 1111-1115[Abstract/Free Full Text]
32. Burgoyne, R. D., and Barclay, J. W. (2002) Trends Neurosci. 26, 176-178
33. Graham, M. E., O'Callaghan, D. W., McMahon, H. T., and Burgoyne, R. D. (2002) Proc. Natl. Acad. Sci. U. S. A., in press
34. Xu, T., Rammner, B., Margittai, M., Artalejo, A. R., Neher, E., and Jahn, R. (1999) Cell 99, 713-722[CrossRef][Medline] [Order article via Infotrieve]
35. Hua, S.-H., and Charlton, M. P. (1999) Nat. Neurosci. 2, 1078-1083[CrossRef][Medline] [Order article via Infotrieve]
36. Pyle, J. L., Kavalali, E. T., Piedras-Renteria, E. S., and Tsien, R. W. (2000) Neuron 28, 221-231[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Xue, A. Stradomska, H. Chen, N. Brose, W. Zhang, C. Rosenmund, and K. Reim
Complexins facilitate neurotransmitter release at excitatory and inhibitory synapses in mammalian central nervous system
PNAS, June 3, 2008; 105(22): 7875 - 7880.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Z. Zhang and M. B. Jackson
Temperature Dependence of Fusion Kinetics and Fusion Pores in Ca2+-triggered Exocytosis from PC12 Cells
J. Gen. Physiol., January 28, 2008; 131(2): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Vardjan, M. Stenovec, J. Jorgacevski, M. Kreft, and R. Zorec
Elementary properties of spontaneous fusion of peptidergic vesicles: fusion pore gating
J. Physiol., December 15, 2007; 585(3): 655 - 661.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Li, G. J. Augustine, and K. Weninger
Kinetics of Complexin Binding to the SNARE Complex: Correcting Single Molecule FRET Measurements for Hidden Events
Biophys. J., September 15, 2007; 93(6): 2178 - 2187.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
O. Larina, P. Bhat, J. A. Pickett, B. S. Launikonis, A. Shah, W. A. Kruger, J. M. Edwardson, and P. Thorn
Dynamic Regulation of the Large Exocytotic Fusion Pore in Pancreatic Acinar Cells
Mol. Biol. Cell, September 1, 2007; 18(9): 3502 - 3511.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. G. Garcia, A. M. Garcia-De-Diego, L. Gandia, R. Borges, and J. Garcia-Sancho
Calcium signaling and exocytosis in adrenal chromaffin cells.
Physiol Rev, October 1, 2006; 86(4): 1093 - 1131.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. G. Giraudo, W. S. Eng, T. J. Melia, and J. E. Rothman
A Clamping Mechanism Involved in SNARE-Dependent Exocytosis
Science, August 4, 2006; 313(5787): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Nolan, A. E. Cowan, D. E. Koppel, H. Jin, and E. Grote
FUS1 Regulates the Opening and Expansion of Fusion Pores between Mating Yeast
Mol. Biol. Cell, May 1, 2006; 17(5): 2439 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Obermuller, A. Lindqvist, J. Karanauskaite, J. Galvanovskis, P. Rorsman, and S. Barg
Selective nucleotide-release from dense-core granules in insulin-secreting cells
J. Cell Sci., September 15, 2005; 118(18): 4271 - 4282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. L. Constable, M. E. Graham, A. Morgan, and R. D. Burgoyne
Amisyn Regulates Exocytosis and Fusion Pore Stability by Both Syntaxin-dependent and Syntaxin-independent Mechanisms
J. Biol. Chem., September 9, 2005; 280(36): 31615 - 31623.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Glynn, C. J. Drew, K. Reim, N. Brose, and A. J. Morton
Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits
Hum. Mol. Genet., August 15, 2005; 14(16): 2369 - 2385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Graham, J. W. Barclay, and R. D. Burgoyne
Syntaxin/Munc18 Interactions in the Late Events during Vesicle Fusion and Release in Exocytosis
J. Biol. Chem., July 30, 2004; 279(31): 32751 - 32760.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Abderrahmani, G. Niederhauser, V. Plaisance, M.-E. Roehrich, V. Lenain, T. Coppola, R. Regazzi, and G. Waeber
Complexin I regulates glucose-induced secretion in pancreatic {beta}-cells
J. Cell Sci., May 1, 2004; 117(11): 2239 - 2247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Rickman, D. A. Archer, F. A. Meunier, M. Craxton, M. Fukuda, R. D. Burgoyne, and B. Davletov
Synaptotagmin Interaction with the Syntaxin/SNAP-25 Dimer Is Mediated by an Evolutionarily Conserved Motif and Is Sensitive to Inositol Hexakisphosphate
J. Biol. Chem., March 26, 2004; 279(13): 12574 - 12579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Edwardson, C.-T. Wang, B. Gong, A. Wyttenbach, J. Bai, M. B. Jackson, E. R. Chapman, and A. J. Morton
Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II
J. Biol. Chem., August 15, 2003; 278(33): 30849 - 30853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. G. Duman and J. G. Forte
What is the role of SNARE proteins in membrane fusion?
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C237 - C249.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. Redecker, M. R. Kreutz, J. Bockmann, E. D. Gundelfinger, and T. M. Boeckers
Brain Synaptic Junctional Proteins at the Acrosome of Rat Testicular Germ Cells
J. Histochem. Cytochem., June 1, 2003; 51(6): 809 - 819.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. D. Burgoyne and A. Morgan
Secretory Granule Exocytosis
Physiol Rev, April 1, 2003; 83(2): 581 - 632.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/21/18249    most recent
C200166200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Archer, D. A.
Right arrow Articles by Burgoyne, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Archer, D. A.
Right arrow Articles by Burgoyne, R. D.
Social Bookmarking